サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1777856

バイオロジカルイメージング試薬の世界市場

Biological Imaging Reagents

出版日
ページ情報
英文 340 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.64円
バイオロジカルイメージング試薬の世界市場
出版日: 2025年07月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 340 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バイオロジカルイメージング試薬の世界市場は2030年までに180億米ドルに達する見込み

2024年に126億米ドルと推定されるバイオロジカルイメージング試薬の世界市場は、2024年から2030年にかけてCAGR 6.2%で成長し、2030年には180億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである造影試薬は、CAGR 7.1％を記録し、分析期間終了までに105億米ドルに達すると予測されます。光学試薬セグメントの成長率は、分析期間でCAGR 5.6%と推定されます。

米国市場は34億米ドルと推定、中国はCAGR9.9%で成長予測

米国のバイオロジカルイメージング試薬市場は、2024年に34億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR 9.9%を牽引し、2030年までに37億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.0％と6.1％と予測されています。欧州では、ドイツがCAGR 4.1%で成長すると予測されています。

世界のバイオロジカルイメージング試薬市場- 主要動向と促進要因のまとめ

バイオロジカルイメージング試薬が現代の診断・調査に欠かせない理由とは？

バイオロジカルイメージング試薬は、メディカルイメージング、ライフサイエンス研究、医薬品開発の進歩に不可欠です。蛍光色素、造影剤、放射性トレーサーを含むこれらの試薬は、分子や細胞のイメージングに使用される可視化技術を向上させる上で重要な役割を果たしています。高解像度のイメージングと生物学的プロセスのリアルタイム追跡を可能にするこれらの能力は、様々な医療用途における診断と治療モニタリングに変革をもたらしつつあります。がんや神経疾患などの慢性疾患の増加により、精密な画像診断ソリューションに対する需要が高まっており、バイオロジカルイメージング試薬は疾患の早期発見や治療計画に不可欠なものとなっています。MRI、PET、CT、蛍光顕微鏡などのイメージング・モダリティが進化するにつれて、特異性と生体適合性を向上させた高度な試薬の必要性が高まっています。さらに、個別化医療へのシフトは、標的診断や患者固有の治療アプローチを促進する分子イメージング試薬の需要を促進しています。

技術の進歩はどのようにイメージング試薬の効率を高めているのか？

ナノテクノロジー、人工知能、生物工学の統合は、バイオロジカルイメージング試薬の効率と特異性を著しく向上させています。ナノ粒子ベースの造影剤における革新は、より深い組織への浸透と撮影時間の延長を可能にし、内部構造をより詳細に可視化することを可能にしています。さらに、pHや酵素活性などの環境変化に反応するスマートイメージング試薬は、疾病診断の精度を高めています。人工知能は、医療スキャンにおける画像再構成、ノイズ除去、パターン認識を改善することで、イメージング試薬の応用を最適化する上で重要な役割を果たしています。AI支援イメージング技術は、膨大なデータセットを高い精度で解析し、イメージング試薬の診断能力を高めることができます。さらに、診断機能と治療機能を併せ持つ多機能イメージング試薬（セラノスティクス）の開発により、がん治療における新たな可能性が開かれつつあり、標的治療を行いながら治療効果をリアルタイムでモニタリングできるようになっています。

どのような市場動向がバイオロジカルイメージング試薬の採用を促進しているのでしょうか？

バイオロジカルイメージング試薬市場を形成する主要動向の一つは、非侵襲的診断技術への注目の高まりです。ヘルスケアプロバイダーや研究者は、高精度の結果を提供しながら患者の不快感を軽減するイメージングソリューションを優先しています。この動向は、外科的介入を必要とせずに分子レベルでの可視化を強化する新規イメージング薬剤への投資を促進しています。もう一つの大きな市場動向は、製薬企業と画像技術開発企業との協力関係の拡大です。新規イメージング試薬を用いた前臨床試験や臨床試験の拡大により、創薬や治療評価が加速しています。さらに、神経科学、腫瘍学、心血管研究の分野では、リアルタイムのin vivoイメージングソリューションに対する需要が高まっており、市場拡大をさらに後押ししています。イメージングモダリティの改善に対するニーズが高まり続ける中、各メーカーはより安全で効率的、かつターゲットを絞った開発に注力しています。

バイオロジカルイメージング試薬市場の主な成長促進要因は？

バイオロジカルイメージング試薬市場の成長は、イメージング技術の進歩、慢性疾患の有病率の増加、臨床診断における分子イメージングの採用増加など、いくつかの要因によってもたらされます。ハイブリッドイメージングシステム（PET-MRI、SPECT-CT）のようなイメージングプラットフォームの継続的な進化は、コントラストとイメージング解像度を高める特殊な試薬の需要を押し上げています。バイオテクノロジーと製薬研究の拡大も、創薬、バイオマーカー同定、疾患病理学研究に不可欠なツールであるため、主要な成長促進要因となっています。さらに、精密医療と個別化ヘルスケアへの投資の増加は、診断精度と治療効果を向上させる標的イメージング薬剤の必要性を高めています。疾病の早期発見、低侵襲診断、AI支援画像ソリューションへの注目の高まりにより、バイオロジカルイメージング試薬市場は堅調な成長を遂げ、医療画像診断と生物医学研究の未来を形成しています。

セグメント

製品タイプ（造影、光学、核）、イメージングモダリティ（光学、MRI、超音波、X線・CT、核）、用途（臨床診断、創薬開発、研究開発、その他）、最終用途（画像診断センター、病院、研究・学術機関、その他）

調査対象企業の例

  • ABX advanced biochemical compounds GmbH
  • Advanced Proteome Therapeutics Corporation
  • Bayer AG
  • Beckman Coulter Inc.
  • BIOPRO Baden-Wurttemberg GmbH
  • Cardinal Health
  • Cell Signaling Technology
  • Danaher Corporation
  • FujiFilm VisualSonics, Inc.
  • General Electric Company
  • Guerbet GmbH
  • Jubilant Pharmova Ltd.
  • Koninklijke Philips NV
  • Nikon Corporation
  • Novartis AG
  • Olympus Corporation
  • PerkinElmer
  • Philips Healthcare
  • Promega Corporation
  • Sartorius AG
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP29585

Global Biological Imaging Reagents Market to Reach US$18.0 Billion by 2030

The global market for Biological Imaging Reagents estimated at US$12.6 Billion in the year 2024, is expected to reach US$18.0 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Contrast Reagents, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$10.5 Billion by the end of the analysis period. Growth in the Optical Reagents segment is estimated at 5.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.4 Billion While China is Forecast to Grow at 9.9% CAGR

The Biological Imaging Reagents market in the U.S. is estimated at US$3.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.7 Billion by the year 2030 trailing a CAGR of 9.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Biological Imaging Reagents Market - Key Trends & Drivers Summarized

Why Are Biological Imaging Reagents Essential in Modern Diagnostics and Research?

Biological imaging reagents are integral to the advancements in medical imaging, life sciences research, and drug development. These reagents, including fluorescent dyes, contrast agents, and radiotracers, play a crucial role in enhancing visualization techniques used in molecular and cellular imaging. Their ability to provide high-resolution imaging and real-time tracking of biological processes is transforming diagnostics and therapeutic monitoring across a range of medical applications. The increasing prevalence of chronic diseases, such as cancer and neurological disorders, has heightened the demand for precise imaging solutions, making biological imaging reagents indispensable in early disease detection and treatment planning. As imaging modalities such as MRI, PET, CT, and fluorescence microscopy evolve, the need for advanced reagents that offer improved specificity and biocompatibility is growing. Furthermore, the shift toward personalized medicine is driving demand for molecular imaging reagents that facilitate targeted diagnostics and patient-specific treatment approaches.

How Are Technological Advancements Enhancing the Efficiency of Imaging Reagents?

The integration of nanotechnology, artificial intelligence, and bioengineering is significantly improving the efficiency and specificity of biological imaging reagents. Innovations in nanoparticle-based contrast agents are enabling deeper tissue penetration and prolonged imaging durations, allowing for more detailed visualization of internal structures. Additionally, smart imaging reagents that respond to environmental changes, such as pH or enzyme activity, are enhancing the precision of disease diagnostics. Artificial intelligence is playing a crucial role in optimizing imaging reagent application by improving image reconstruction, noise reduction, and pattern recognition in medical scans. AI-assisted imaging technologies can analyze vast datasets with high accuracy, increasing the diagnostic capabilities of imaging reagents. Furthermore, the development of multifunctional imaging agents, which combine diagnostic and therapeutic functionalities (theranostics), is opening new opportunities in cancer treatment, enabling real-time monitoring of treatment efficacy while delivering targeted therapy.

What Market Trends Are Driving the Adoption of Biological Imaging Reagents?

One of the key trends shaping the biological imaging reagents market is the increasing focus on non-invasive diagnostic techniques. Healthcare providers and researchers are prioritizing imaging solutions that reduce patient discomfort while delivering high-precision results. This trend is driving investments in novel imaging agents that enhance visualization at the molecular level without requiring surgical intervention. Another significant market trend is the growing collaboration between pharmaceutical companies and imaging technology developers. The expansion of preclinical and clinical trials involving novel imaging reagents is accelerating drug discovery and therapeutic assessment. Additionally, the demand for real-time, in vivo imaging solutions is growing in the field of neuroscience, oncology, and cardiovascular research, further propelling market expansion. As the need for improved imaging modalities continues to rise, manufacturers are focusing on developing safer, more efficient, and highly targeted biological imaging reagents.

What Are the Key Growth Drivers for the Biological Imaging Reagents Market?

The growth in the Biological Imaging Reagents market is driven by several factors, including advancements in imaging technologies, increasing prevalence of chronic diseases, and the rising adoption of molecular imaging in clinical diagnostics. The continuous evolution of imaging platforms, such as hybrid imaging systems (PET-MRI, SPECT-CT), is boosting the demand for specialized reagents that enhance contrast and imaging resolution. The expansion of biotechnology and pharmaceutical research is also a major growth driver, as biological imaging reagents are essential tools for drug discovery, biomarker identification, and disease pathology research. Furthermore, the increasing investments in precision medicine and personalized healthcare are driving the need for targeted imaging agents that improve diagnostic accuracy and treatment efficacy. With the growing focus on early disease detection, minimally invasive diagnostics, and AI-assisted imaging solutions, the biological imaging reagents market is poised for robust growth, shaping the future of medical imaging and biomedical research.

SCOPE OF STUDY:

The report analyzes the Biological Imaging Reagents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Contrast Reagents, Optical Reagents, Nuclear Reagents); Imaging Modality (Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality, Nuclear Imaging Modality); Application (Clinical Diagnostics Application, Drug Discovery and Development Application, Research and #innovation Application, Other Applications); End-Use (Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research and Academic Institutes End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • ABX advanced biochemical compounds GmbH
  • Advanced Proteome Therapeutics Corporation
  • Bayer AG
  • Beckman Coulter Inc.
  • BIOPRO Baden-Wurttemberg GmbH
  • Cardinal Health
  • Cell Signaling Technology
  • Danaher Corporation
  • FujiFilm VisualSonics, Inc.
  • General Electric Company
  • Guerbet GmbH
  • Jubilant Pharmova Ltd.
  • Koninklijke Philips NV
  • Nikon Corporation
  • Novartis AG
  • Olympus Corporation
  • PerkinElmer
  • Philips Healthcare
  • Promega Corporation
  • Sartorius AG
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Biological Imaging Reagents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases and Cancer Propels Demand for Advanced Imaging Reagents
    • Technological Innovations in Molecular Imaging Strengthen Business Case for Targeted Reagents
    • Growth in Personalized Medicine and Precision Diagnostics Expands Addressable Market for Imaging Reagents
    • Increased Research in Cell Biology and Pathology Throws Spotlight on Novel Imaging Biomarkers
    • Integration with AI and Imaging Software Enhances Accuracy and Interpretation of Imaging Reagents
    • Expansion of Preclinical and Translational Research Generates Demand for Specialized Reagent Kits
    • Funding for Biomedical Research Sustains Growth in Academic and Institutional Adoption
    • High Demand for Non-Invasive Diagnostic Tools Spurs Adoption of Biocompatible Imaging Reagents
    • Shift Toward Multimodal Imaging Techniques Generates Demand for Versatile Imaging Reagents
    • Commercialization of Novel Nanoparticle-Based Reagents Expands Application Scope in Oncology
    • Increased Focus on Live-Cell Imaging and Real-Time Monitoring Drives Innovation in Reagent Design
    • Rising Use in Companion Diagnostics Enhances Market Relevance in Targeted Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biological Imaging Reagents Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biological Imaging Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Biological Imaging Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Contrast Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Contrast Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Optical Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Optical Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Nuclear Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Nuclear Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Research & #innovation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Research & #innovation Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Clinical Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Clinical Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Diagnostic Imaging Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Research & Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Research & Academic Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Optical Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Optical Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for MRI Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for MRI Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Ultrasound Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Ultrasound Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for X-ray and CT Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for X-ray and CT Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Nuclear Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Nuclear Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 36: USA Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • JAPAN
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • CHINA
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 60: China Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • EUROPE
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Biological Imaging Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • FRANCE
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 78: France Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • GERMANY
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • ITALY
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Italy 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • UNITED KINGDOM
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 102: UK Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: UK 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Spain 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 112: Spain Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Spain 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 114: Spain Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Spain 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • RUSSIA
    • TABLE 118: Russia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Russia 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 120: Russia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Russia 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 124: Russia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Russia 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 132: Rest of Europe Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of Europe 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • AUSTRALIA
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 144: Australia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Australia 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 146: Australia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Australia 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 148: Australia Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Australia 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 150: Australia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Australia 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • INDIA
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 152: India Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: India 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 154: India Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 155: India 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 156: India Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 157: India 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 158: India Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: India 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • SOUTH KOREA
    • TABLE 160: South Korea Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 161: South Korea 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 162: South Korea Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 163: South Korea 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 164: South Korea Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: South Korea 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 166: South Korea Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 167: South Korea 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 168: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 169: Rest of Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 170: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 172: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 173: Rest of Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 174: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 175: Rest of Asia-Pacific 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • LATIN AMERICA
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 176: Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 177: Latin America 6-Year Perspective for Biological Imaging Reagents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030
    • TABLE 178: Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 179: Latin America 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 180: Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 181: Latin America 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 182: Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Latin America 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 184: Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 185: Latin America 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • ARGENTINA
    • TABLE 186: Argentina Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 187: Argentina 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 188: Argentina Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Argentina 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 190: Argentina Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 191: Argentina 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 192: Argentina Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 193: Argentina 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • BRAZIL
    • TABLE 194: Brazil Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Brazil 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 196: Brazil Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 197: Brazil 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 198: Brazil Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 199: Brazil 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 200: Brazil Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Brazil 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • MEXICO
    • TABLE 202: Mexico Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 203: Mexico 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 204: Mexico Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 205: Mexico 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 206: Mexico Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Mexico 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 208: Mexico Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 209: Mexico 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 210: Rest of Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 211: Rest of Latin America 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 212: Rest of Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Latin America 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 214: Rest of Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 215: Rest of Latin America 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 216: Rest of Latin America Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 217: Rest of Latin America 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • MIDDLE EAST
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 218: Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 219: Middle East 6-Year Perspective for Biological Imaging Reagents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030
    • TABLE 220: Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 221: Middle East 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 222: Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 223: Middle East 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 224: Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Middle East 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 226: Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 227: Middle East 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • IRAN
    • TABLE 228: Iran Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 229: Iran 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 230: Iran Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Iran 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 232: Iran Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 233: Iran 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 234: Iran Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 235: Iran 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • ISRAEL
    • TABLE 236: Israel Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Israel 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 238: Israel Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 239: Israel 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 240: Israel Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 241: Israel 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 242: Israel Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Israel 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • SAUDI ARABIA
    • TABLE 244: Saudi Arabia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 245: Saudi Arabia 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 246: Saudi Arabia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 247: Saudi Arabia 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 248: Saudi Arabia Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Saudi Arabia 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 250: Saudi Arabia Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 251: Saudi Arabia 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 252: UAE Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 253: UAE 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 254: UAE Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: UAE 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 256: UAE Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 257: UAE 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 258: UAE Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 259: UAE 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 260: Rest of Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Rest of Middle East 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 262: Rest of Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 263: Rest of Middle East 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 264: Rest of Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 265: Rest of Middle East 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 266: Rest of Middle East Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Rest of Middle East 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • AFRICA
    • Biological Imaging Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 268: Africa Recent Past, Current & Future Analysis for Biological Imaging Reagents by Product Type - Contrast Reagents, Optical Reagents and Nuclear Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 269: Africa 6-Year Perspective for Biological Imaging Reagents by Product Type - Percentage Breakdown of Value Sales for Contrast Reagents, Optical Reagents and Nuclear Reagents for the Years 2025 & 2030
    • TABLE 270: Africa Recent Past, Current & Future Analysis for Biological Imaging Reagents by Application - Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 271: Africa 6-Year Perspective for Biological Imaging Reagents by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research & #innovation Application, Other Applications and Clinical Diagnostics Application for the Years 2025 & 2030
    • TABLE 272: Africa Recent Past, Current & Future Analysis for Biological Imaging Reagents by End-Use - Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Africa 6-Year Perspective for Biological Imaging Reagents by End-Use - Percentage Breakdown of Value Sales for Diagnostic Imaging Centers End-Use, Hospitals End-Use, Research & Academic Institutes End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 274: Africa Recent Past, Current & Future Analysis for Biological Imaging Reagents by Imaging Modality - Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 275: Africa 6-Year Perspective for Biological Imaging Reagents by Imaging Modality - Percentage Breakdown of Value Sales for Optical Imaging Modality, MRI Imaging Modality, Ultrasound Imaging Modality, X-ray and CT Imaging Modality and Nuclear Imaging Modality for the Years 2025 & 2030

IV. COMPETITION